Outlook Therapeutics, Inc. (OTLK) earnings
Quarterly results of Outlook Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Outlook Therapeutics, Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended June 30, 2026) Outlook Therapeutics, Inc. reported revenue of - and a net loss of $20.3M.
Diluted earnings per share were -$0.15.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | - | - | -$20.3M | -$0.15 |
| Q2 FY2026 | - | - | -$4.5M | -$0.05 |
| Q1 FY2026 | - | - | -$23.1M | -$0.38 |
| Q4 FY2025 | - | - | -$13.3M | - |
| Q3 FY2025 | $1.5M | - | -$20.2M | -$0.55 |
| Q2 FY2025 | - | - | -$46.4M | -$1.50 |
| Q1 FY2025 | - | - | $17.4M | $0.72 |
| Q4 FY2024 | - | - | $5.7M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
When is Outlook Therapeutics, Inc.'s next earnings date?
Outlook Therapeutics, Inc. was expected to report around November 9, 2026; nothing is on file with the SEC yet.
Get an email when OTLK reports
Follow OTLK and we email you its next results the day they are filed, with the numbers explained.